Showing results (421-430 of 5,265) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|October 1, 1991
Immune function parameters at diagnosis in patients with myelodysplastic syndromes: correlation with the FAB classification and prognosisA Symeonidis, A Kourakli, P Katevas, et al.
European Journal of Haematology|October 1, 1991
Increased serum neopterin concentration as indicator of disease severity and poor survival in multiple myelomaM Boccadoro, S Battaglio, P Omedè, et al.
European Journal of Haematology|July 24, 2009
Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomibJiri Minarik, Vlastimil Scudla, Marta Ordeltova, et al.
European Journal of Haematology|August 19, 2009
Paroxysmal nocturnal haemoglobinuria: diagnostic tests, advantages, & limitationsManisha Madkaikar, Maya Gupta, Farah Jijina, et al.
European Journal of Haematology|September 10, 2009
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasiaEleftheria Hatzimichael, Aggeliki Dasoula, Reshma Shah, et al.
European Journal of Haematology|September 12, 2009
Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia majorMeropi Dimitriadou, Athanasios Christoforidis, Marina Economou, et al.
European Journal of Haematology|April 9, 2010
Combined 677CC/1298AC genotypes of methylenetetrahydrofolate reductase (MTHFR ) reduce susceptibility to precursor B lymphoblastic leukemia in a Chinese populationLing Lv, Cuie Wu, Henjuan Sun, et al.
European Journal of Haematology|April 9, 2010
BSc2118 is a novel proteasome inhibitor with activity against multiple myelomaJan Sterz, Christian Jakob, Ulrike Kuckelkorn, et al.
European Journal of Haematology|June 25, 2009
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromesJudith Neukirchen, Sabine Blum, Andrea Kuendgen, et al.
European Journal of Haematology|April 24, 2009
Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up studyAnders Wahlin, Rolf Billström, Ove Björ, et al.
Pageof 527